SM-01 APPLICATION OF BEVACIZUMAB TO POST-IRRADIATED CEREBRAL LESION: DIAGNOSIS, INTERVENTION AND OUTCOME

BACKGROUND: Taking results of AVAglio (Chinot et al., 2014), BRAIN study (Friedman et al., 2009) and JO22506 (Nagane et al., 2012), bevacizumab (BEV) had been approved for the treatment of newly diagnosed and recurrent malignant glioma. In addition, there are some trials using BEV for symptomatic ce...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neuro Oncol
Huvudupphovsmän: Fukui, Nobuyuki, Arakawa, Yoshiki, Murata, Daiki, Fujimoto, Koichi, Miyamoto, Susumu
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2014
Ämnen:
Abstracts
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218610/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou277.1
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk